Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Considerations for Operationalizing Pediatric Oncology Studies By Premier Research December 18, 2019 Patient and Stakeholder Engagement Chance Connections Become New Relationships at Global Genes By Premier Research November 20, 2019 Consulting A Security Plan for All Stakeholders Involved in Digital Medicine: What Device Manufacturers Need to Know By Premier Research July 10, 2019 Consulting Regulatory Oversight on Gene Therapy in the U.S. and EU By Premier Research March 8, 2019 Medical and Regulatory Affairs Brexit is Pressuring Sponsors. Here’s How We’re Responding. By Premier Research February 20, 2019 Medical and Regulatory Affairs Draft Guidance: Hematologic Malignancies: Regulatory Considerations for Use of Minimal Residual Disease in Development of Drug and Biological Products for Treatment By Premier Research November 5, 2018 Previous 1 …4 5 6 7 8 … 18 Next × ALSO OF INTEREST6 Existing Therapeutic Strategies for Acne ManagementGene Therapy 101: From the 1960s to TodayDesigning Pediatric Analgesic Treatment...